# Blackbaud Inc. (BLKB) fundamentals

Data as of 2026-11-04. NASDAQ, United States. Sector: Technology / Software. Price $54.21, market value $2.4 billion.

## Valuation
- **P/E (trailing): 16.7×** (5-yr avg 710.0×, 3-yr avg 735.9×). Blackbaud Inc. trades at 16.7× trailing earnings, well below its own five-year average of 710.0×: cheap by its own standards. The Technology median in the September 2026 study was 32.1×. Forward P/E is 9.0×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.06**. A PEG of 0.06 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 2.1×**. Each dollar of revenue is priced at 2.1×.
- **Price / book: 20.2×**. The shares trade at 20.2× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **EV / EBITDA: 11.1×**. Enterprise value is 11.1× operating earnings before depreciation, the multiple that ignores how the company is financed.
- **Free-cash-flow yield: 13.6%** (5-yr avg 6.4%). Free cash flow equals 13.6% of the market value, above its five-year average of 6.4%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.
- **Earnings yield: 6.0%**. The inverse of the P/E: 6.0% of the price is earned each year.

## Profitability
- **Gross margin: 59.9%**. Blackbaud Inc. keeps 59.9% of revenue after the direct cost of what it sells.
- **Operating margin: 20.1%**. 20.1% of revenue is left after running the business, a healthy level in most sectors.
- **Net margin: 10.2%**. 10.2% of each dollar of sales reaches the bottom line.
- **Return on equity: 135.2%**. A 135.2% return on equity is extremely high; check whether buybacks or debt have shrunk the equity base, which flatters the ratio.
- **Return on invested capital: 15.9%**. Return on all capital, debt included, is 15.9%: comfortably above what that capital costs.
- **Return on assets: 6.2%**. Each dollar of assets produces 6.2% of profit.

## Growth
- **Revenue growth (1 yr): -2.3%** (3-yr 2.2%/yr, 5-yr 4.3%/yr). Revenue fell 2.3% over the last year, against 4.3% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 140.0%** (5-yr 71.4%/yr). Earnings per share rose 140.0%, faster than revenue, so margins expanded or the share count shrank.
- **Free-cash-flow growth (3 yr): 10.4%/yr**. Free cash flow has compounded at 10.4% a year over three years.

## Financial health
- **Debt to equity: 13.05**. Debt is 13.05 times equity, a leveraged balance sheet that needs steady cash flow to service.
- **Net debt / EBITDA: 3.4×**. It would take 3.4 years of operating earnings to repay net borrowings, above the 3× level most lenders treat as comfortable.
- **Current ratio: 0.79** (quick 0.79). Current liabilities exceed current assets, so the company depends on ongoing cash generation or refinancing to pay the next year's bills.
- **Altman Z-score: 1.29**. A Z-score of 1.29 is in the distress zone, a signal to examine the balance sheet closely.
- **Piotroski F-score: 8/9**. 8 of 9 fundamental checks pass: strong and improving financials.

## Dividends
- **Dividend: none**. Blackbaud Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: buy** (4 analysts). 4 analysts cover Blackbaud Inc.; the consensus is buy, with an average price target of $55.00 (+1% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -15.0%** (YTD -14.0%, 3-mo 22.7%). The shares are down 15.0% over twelve months including dividends.
- **From 52-week high: -16.4%** (111.9% above the low). Trading 16% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 68**. An RSI of 68 is neutral.
- **Beta (1 yr): 0.24** (volatility 49%). Beta of 0.24 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=BLKB · Page: https://foliofundamentals.com/stocks/blkb

Not investment advice.